Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The price of Boundless Bio Inc (NASDAQ: BOLD) closed at $1.1 in the last session, up 1.85% from day before closing price of $1.08. In other words, the price has increased by $1.85 from its previous closing price. On the day, 0.17 million shares were traded. BOLD stock price reached its highest trading level at $1.12 during the session, while it also had its lowest trading level at $1.0535.
Ratios:
We take a closer look at BOLD’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.14 and its Current Ratio is at 10.14. In the meantime, Its Debt-to-Equity ratio is 0.45 whereas as Long-Term Debt/Eq ratio is at 0.42.
Upgrades & Downgrades
In the most recent recommendation for this company, H.C. Wainwright on June 02, 2025, initiated with a Buy rating and assigned the stock a target price of $5.
On May 28, 2025, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $3.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BOLD now has a Market Capitalization of 24624174 and an Enterprise Value of -43188456.
Stock Price History:
The Beta on a monthly basis for BOLD is -0.05, which has changed by -0.6183746 over the last 52 weeks, in comparison to a change of 0.12469888 over the same period for the S&P500. Over the past 52 weeks, BOLD has reached a high of $3.54, while it has fallen to a 52-week low of $1.00. The 50-Day Moving Average of the stock is -12.73%, while the 200-Day Moving Average is calculated to be -16.14%.
Shares Statistics:
According to the various share statistics, BOLD traded on average about 143.87K shares per day over the past 3-months and 244320 shares per day over the past 10 days. A total of 22.39M shares are outstanding, with a floating share count of 15.91M. Insiders hold about 28.92% of the company’s shares, while institutions hold 37.50% stake in the company. Shares short for BOLD as of 1763078400 were 61538 with a Short Ratio of 0.43, compared to 1760486400 on 136526. Therefore, it implies a Short% of Shares Outstanding of 61538 and a Short% of Float of 0.47999998000000005.
Earnings Estimates
. The current assessment of Boundless Bio Inc (BOLD) involves the perspectives of 3.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.57, with high estimates of -$0.49 and low estimates of -$0.66.
Analysts are recommending an EPS of between -$2.45 and -$2.51 for the fiscal current year, implying an average EPS of -$2.47. EPS for the following year is -$2.1, with 3.0 analysts recommending between -$1.81 and -$2.51.
